Maryland's Defense Patent Database

The defense community in Maryland is an R&D powerhouse.

Use this database to see the innovative patents that are poised for commercialization.

Recombinant antigens for diagnosis and prevention of spotted fever rickettsiae

Patent image
NMRC

The invention relates to the construction of recombinant, immunodominant polypeptides against spotted fever group Rickettsia. The invention also relates to a method for the use of the recombinant proteins, either singly or in combination, in detection and diagnostic assays of spotted fever. The proteins can also be used to induce immune response against spotted fever group Rickettsia.

Inventors: 
Ching, Wei-mei
Patent Number: 
Technical domain: 
Biotechnology and Healthcare
FIle Date: 
2009-06-08
Grant Date: 
2014-01-07
Grant time: 
1,674 days
Grant time percentile rank: 
30
Claim count percentile rank: 
3
Citations percentile rank: 
1
'Cited by' percentile rank: 
1
Assignee: 
US NAVY